Mitomycin C, doxorubicin and 5-fluorouracil may not improve survival over 5-fluorouracil alone in people with curatively resected gastric cancer: Abstracted from: Chang H, Jung K, Kim T et al. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Annals of Oncology 2002; 13: 1779–85

✍ Scribed by Qingguo Fu

• Book ID: 117487704
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 65 KB
• Volume: 29
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/s0305-7372(03)00019-7